JAMA Internal Medicine
JANUARY 26, 2025
This cohort study assesses the severity and long-term mortality of COVID-19, influenza, and respiratory syncytial virus in a large cohort of nonhospitalized veterans.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 26, 2025
(PhotoAlto/Antoine Arraou/Getty Images) Would you give up your sense of smell to keep your hair? What about your phone? A 2022 US study compared smell to other senses (sight and hearing) and personally prized commodities (including money, a pet, or hair) to see what people valued more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
JANUARY 26, 2025
This prognostic study develops and validates 5 novel termination of resuscitation rules for in-hospital cardiac arrest.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 26, 2025
The Central Drugs Standard Control Organization (CDSCO) has issued an urgent call for inputs from pharmaceutical industry stakeholders to identify current challenges within the existing regulatory framework. This call is also to explore opportunities for streamlining processes without compromising the quality of medical products.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JANUARY 26, 2025
The Battle for Generic Medications: A Recent Patent Dispute As we continue to navigate the complex world of pharmaceuticals, it's essential to stay informed about the latest developments in patent disputes. Recently, Astellas Pharma Inc. found itself in a high-stakes battle with Creekwood Pharmaceuticals LLC over the rights to a generic version of their medication.
JAMA Internal Medicine
JANUARY 26, 2025
This Viewpoint discusses potential changes to sexual and gender minority health care under the Trump-Vance administration.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
JANUARY 26, 2025
The Battle for Sleep: A Patent Dispute that Could Shake the CNS Market As we navigate the complexities of the pharmaceutical industry, it's not uncommon to come across disputes over patents and intellectual property. But the recent case of Avadel CNS Pharmaceuticals LLC v. Jazz Pharmaceuticals Inc. is one that's caught our attention. At the heart of this dispute is the patent for Xyrem, a medication used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy.
Drug Patent Watch
JANUARY 26, 2025
The Battle for Generic Medications: A Look at Pfizer Inc. v. Alkem Laboratories Limited As we navigate the complex world of pharmaceuticals, it's essential to understand the intricacies of patent law and its impact on the availability of generic medications. A recent case, Pfizer Inc. v. Alkem Laboratories Limited, has shed light on the challenges faced by generic manufacturers and the importance of patent protection.
Drug Patent Watch
JANUARY 26, 2025
Patent Disputes in the Global Market: A Cautionary Tale As a business leader, you're likely no stranger to the world of intellectual property and patent disputes. But have you ever stopped to think about the real-world implications of these disputes on your company's bottom line? Take the case of Taizhou Luqiao Shengqiang Housewares Factory v. DBest Products Inc.
Expert insights. Personalized for you.
84 
Let's personalize your content